Breast cancer drug 'could be safe treatment' for reducing obesity and diabetes

Breast cancer drug 'could be safe treatment' for reducing obesity and diabetes

A drug initially designed to fight breast cancer could be a safe treatment for obesity and diabetes, according to researchers at the University of Aberdeen.

The team have been studying the complex connections between obesity and type-2 diabetes which is an increasingly important area of bio-medical research.  

Tests using a drug called Fenretinide, which has been used in breast cancer trials for a number of years, revealed it can reduce obesity and type-2 diabetes in mice that eat a high-fat diet.

In a new paper, published in Biochemical Pharmacology, the team led by Dr Nimesh Mody, a lecturer at the University of Aberdeen’s Institute of Medical Sciences have discovered more about how Fenretinide works and have deemed it a potentially safe, anti-obesity, anti-diabetic treatment.

Obesity and type-2 diabetes present a major public health challenge. Researchers are attempting to further understand the complex connections between the two conditions.

Vitamin A and vitamin A-like molecules (called retinoids) have been shown to have major effects on body fat and blood sugar levels and thought to have a role in obesity.

Fenretinide is a retinoid and the Aberdeen team have previously shown that it can prevent or reduce obesity and type-2 diabetes in mice that eat a high-fat diet.

Dr Nimesh Mody said: “In this new publication we have discovered more about how Fenretinide works in fat cells, called adipocytes, and in mice.

“Fenretinide has beneficial effects that are similar to vitamin A but also have the effect of reducing the production of a harmful type of molecule called ceramide. 

“We think that the combination of these unrelated effects is what makes Fenretinide a potential safe, anti-obesity, anti-diabetic treatment.

“Going forward we aim to chemically modify Fenretinide to produce two different versions; one that will retain retinoid-like properties, whilst the other will be lacking them. We will compare the properties, characteristics and effects of these two compounds to see how similar they are to the original Fenretinide. Through these experiments, we aim to find out whether the beneficial effects of Fenretinide in safely reducing obesity and type-2 diabetes is due to retinoid-like properties.

“This information will help us further our understanding of the complex connections between obesity and the development of type-2 diabetes and may help us to develop new drugs that are better at treating these medical conditions.”

Search News

Browse by Month

2024

  1. Jan
  2. Feb There are no items to show for February 2024
  3. Mar
  4. Apr There are no items to show for April 2024
  5. May There are no items to show for May 2024
  6. Jun There are no items to show for June 2024
  7. Jul There are no items to show for July 2024
  8. Aug There are no items to show for August 2024
  9. Sep There are no items to show for September 2024
  10. Oct There are no items to show for October 2024
  11. Nov There are no items to show for November 2024
  12. Dec There are no items to show for December 2024

2023

  1. Jan There are no items to show for January 2023
  2. Feb There are no items to show for February 2023
  3. Mar There are no items to show for March 2023
  4. Apr There are no items to show for April 2023
  5. May There are no items to show for May 2023
  6. Jun There are no items to show for June 2023
  7. Jul There are no items to show for July 2023
  8. Aug There are no items to show for August 2023
  9. Sep There are no items to show for September 2023
  10. Oct
  11. Nov There are no items to show for November 2023
  12. Dec

2022

  1. Jan
  2. Feb There are no items to show for February 2022
  3. Mar
  4. Apr There are no items to show for April 2022
  5. May
  6. Jun There are no items to show for June 2022
  7. Jul
  8. Aug
  9. Sep There are no items to show for September 2022
  10. Oct
  11. Nov There are no items to show for November 2022
  12. Dec There are no items to show for December 2022

2021

  1. Jan There are no items to show for January 2021
  2. Feb
  3. Mar
  4. Apr
  5. May
  6. Jun
  7. Jul
  8. Aug
  9. Sep
  10. Oct
  11. Nov
  12. Dec

2020

  1. Jan
  2. Feb
  3. Mar
  4. Apr
  5. May
  6. Jun
  7. Jul
  8. Aug There are no items to show for August 2020
  9. Sep There are no items to show for September 2020
  10. Oct There are no items to show for October 2020
  11. Nov
  12. Dec

2019

  1. Jan
  2. Feb
  3. Mar There are no items to show for March 2019
  4. Apr
  5. May
  6. Jun
  7. Jul
  8. Aug
  9. Sep
  10. Oct
  11. Nov
  12. Dec

2018

  1. Jan There are no items to show for January 2018
  2. Feb There are no items to show for February 2018
  3. Mar There are no items to show for March 2018
  4. Apr There are no items to show for April 2018
  5. May There are no items to show for May 2018
  6. Jun There are no items to show for June 2018
  7. Jul
  8. Aug
  9. Sep
  10. Oct
  11. Nov
  12. Dec

2017

  1. Jan
  2. Feb There are no items to show for February 2017
  3. Mar
  4. Apr
  5. May
  6. Jun
  7. Jul
  8. Aug There are no items to show for August 2017
  9. Sep
  10. Oct There are no items to show for October 2017
  11. Nov
  12. Dec There are no items to show for December 2017

2016

  1. Jan
  2. Feb
  3. Mar
  4. Apr
  5. May
  6. Jun
  7. Jul
  8. Aug There are no items to show for August 2016
  9. Sep
  10. Oct
  11. Nov There are no items to show for November 2016
  12. Dec

2014

  1. Jan
  2. Feb
  3. Mar
  4. Apr
  5. May
  6. Jun
  7. Jul
  8. Aug
  9. Sep There are no items to show for September 2014
  10. Oct
  11. Nov
  12. Dec

2012

  1. Jan There are no items to show for January 2012
  2. Feb There are no items to show for February 2012
  3. Mar There are no items to show for March 2012
  4. Apr There are no items to show for April 2012
  5. May There are no items to show for May 2012
  6. Jun There are no items to show for June 2012
  7. Jul There are no items to show for July 2012
  8. Aug There are no items to show for August 2012
  9. Sep
  10. Oct
  11. Nov There are no items to show for November 2012
  12. Dec There are no items to show for December 2012